Search

Your search keyword '"Yannoukakos, Drakoulis"' showing total 281 results

Search Constraints

Start Over You searched for: Author "Yannoukakos, Drakoulis" Remove constraint Author: "Yannoukakos, Drakoulis" Publication Type Academic Journals Remove constraint Publication Type: Academic Journals
281 results on '"Yannoukakos, Drakoulis"'

Search Results

1. Ovarian cancer pathology characteristics as predictors of variant pathogenicity in BRCA1 and BRCA2

2. Integrative multi-omics analyses to identify the genetic and functional mechanisms underlying ovarian cancer risk regions

3. Cancer Risks Associated With BRCA1 and BRCA2 Pathogenic Variants

4. Genetic Data from Nearly 63,000 Women of European Descent Predicts DNA Methylation Biomarkers and Epithelial Ovarian Cancer Risk

5. Polygenic risk modeling for prediction of epithelial ovarian cancer risk

6. The BRCA2 c.68‐7T > A variant is not pathogenic: A model for clinical calibration of spliceogenicity

7. Assessment of moderate coffee consumption and risk of epithelial ovarian cancer: a Mendelian randomization study

8. Genetic Testing of Breast Cancer Patients with Very Early-Onset Breast Cancer (≤30 Years) Yields a High Rate of Germline Pathogenic Variants, Mainly in the BRCA1, TP53, and BRCA2 Genes.

9. Polygenic risk scores and breast and epithelial ovarian cancer risks for carriers of BRCA1 and BRCA2 pathogenic variants

11. Genome-Wide Meta-Analyses of Breast, Ovarian, and Prostate Cancer Association Studies Identify Multiple New Susceptibility Loci Shared by at Least Two Cancer Types

12. An intergenic risk locus containing an enhancer deletion in 2q35 modulates breast cancer risk by deregulating IGFBP5 expression

13. RAD51B in Familial Breast Cancer.

14. An original phylogenetic approach identified mitochondrial haplogroup T1a1 as inversely associated with breast cancer risk in BRCA2 mutation carriers

15. A case-only study to identify genetic modifiers of breast cancer risk for BRCA1/BRCA2 mutation carriers

16. Height and Breast Cancer Risk: Evidence From Prospective Studies and Mendelian Randomization

17. Association of type and location of BRCA1 and BRCA2 mutations with risk of breast and ovarian cancer.

18. Inherited variants in the inner centromere protein (INCENP) gene of the chromosomal passenger complex contribute to the susceptibility of ER-negative breast cancer

19. Correction: Polygenic risk modeling for prediction of epithelial ovarian cancer risk

21. Genetic variation in mitotic regulatory pathway genes is associated with breast tumor grade.

22. Genome-wide association study identifies 25 known breast cancer susceptibility loci as risk factors for triple-negative breast cancer.

23. DNA glycosylases involved in base excision repair may be associated with cancer risk in BRCA1 and BRCA2 mutation carriers.

24. Genome-wide association study in BRCA1 mutation carriers identifies novel loci associated with breast and ovarian cancer risk.

29. Publisher Correction: Shared heritability and functional enrichment across six solid cancers

30. Genome-wide association and transcriptome studies identify target genes and risk loci for breast cancer

31. Shared heritability and functional enrichment across six solid cancers

33. Identification of 12 new susceptibility loci for different histotypes of epithelial ovarian cancer

34. Genes associated with histopathologic features of triple negative breast tumors predict molecular subtypes

35. Prediction of Breast Cancer Risk Based on Profiling With Common Genetic Variants

36. Identifying and testing for hereditary susceptibility to breast/ovarian cancer in Serbia: Where are we now?

39. Supplement to: Breast-cancer risk in families with mutations in PALB2.

40. Fine-mapping identifies two additional breast cancer susceptibility loci at 9q31.2

41. Identification and characterization of novel associations in the CASP8/ALS2CR12 region on chromosome 2 with breast cancer risk

42. Prevalence of BRCA1 mutations among 403 women with triple-negative breast cancer: implications for genetic screening selection criteria: a Hellenic Cooperative Oncology Group Study

43. International distribution and age estimation of the Portuguese BRCA2 c.156_157insAlu founder mutation

45. Common non-synonymous SNPs associated with breast cancer susceptibility: findings from the Breast Cancer Association Consortium

46. Breast-Cancer Risk in Families with Mutations in PALB2

47. A large-scale assessment of two-way SNP interactions in breast cancer susceptibility using 46 450 cases and 42 461 controls from the breast cancer association consortium

49. Greek BRCA1 and BRCA2 mutation spectrum: two BRCA1 mutations account for half the carriers found among high-risk breast/ovarian cancer patients

Catalog

Books, media, physical & digital resources